| Bioactivity | SN38-PAB-Lys(MMT)-oxydiacetamide-PEG8-N3 is a Drug-Linker Conjugate for ADC. SN38-PAB-Lys(MMT)-oxydiacetamide-PEG8-N3 consists of the anti-cancer agent SN38 (HY-13704) and a linker Lys(MMT)-PAB-oxydiacetamide-PEG8-N3 (HY-131157). SN38-PAB-Lys(MMT)-oxydiacetamide-PEG8-N3 can be used for synthesis of ADCs[1]. |
| Name | SN38-PAB-Lys(MMT)-oxydiacetamide-PEG8-N3 |
| CAS | 1373170-36-5 |
| Formula | C78H95N9O20 |
| Molar Mass | 1478.64 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Govindan Serengulam V, et al. Antibody-SN-38 immunoconjugates with a CL2A linker. Patent. US20140227180. |
SN38-PAB-Lys(MMT)-oxydiacetamide-PEG8-N3
CAS: 1373170-36-5 F: C78H95N9O20 W: 1478.64
SN38-PAB-Lys(MMT)-oxydiacetamide-PEG8-N3 is a Drug-Linker Conjugate for ADC. SN38-PAB-Lys(MMT)-oxydiacetamide-PEG8-N3 co
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.